Wordt geladen...
Skin toxicity and quality of life during treatment with panitumumab for RAS wild-type metastatic colorectal carcinoma: results from three randomised clinical trials
PURPOSE: Epidermal growth factor receptor inhibitors such as panitumumab are associated with characteristic skin toxicities. We summarise data from three panitumumab clinical trials to investigate the potential impact of skin toxicity on quality of life (QoL) in patients with metastatic colorectal c...
Bewaard in:
| Gepubliceerd in: | Qual Life Res |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer International Publishing
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5010834/ https://ncbi.nlm.nih.gov/pubmed/27083443 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11136-016-1288-4 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|